Preemptive interferon-α treatment could protect against relapse and improve long-term survival of ALL patients after allo-HSCT
Sign Up to like & getrecommendations! Published in 2020 at "Scientific Reports"
DOI: 10.1038/s41598-020-77186-9
Abstract: Relapse was the major cause of treatment failure in patients with acute lymphoblastic leukemia (ALL) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We aimed to identify the efficacy and safety of preemptive interferon-α (IFN-α) treatment… read more here.
Keywords: allo hsct; treatment; ifn treatment; preemptive interferon ... See more keywords